A Randomized Prospective Trial of Three Different Regimens of Treatment of Peritonitis in Patients on Continuous Ambulatory Peritoneal Dialysis

American Journal of Kidney Diseases

Volumn 15, Issue 2, 1990, Pages 155-159

  Chan, Man Kam ^a,b   Cheng, Ignatius K P ^a,b   Ng, Wendy S F ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUNG WAH HOSPITAL   (Hong Kong)

Author keywords

CAPD peritonitis; cephalothin; ofloxacin; rifampicin; tobramycin

Indexed keywords

CEFALOTIN; OFLOXACIN; RIFAMPICIN; TOBRAMYCIN;

ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PERITONITIS;

EID: 0025269515     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(12)80513-0     Document Type: Article

References (12)

1. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis
2. CAPD related peritonitis management and antibiotic therapy recommendations
3. Oral treatment of peritonitis in CAPD patients with ofloxacin
4. Oral treatment of peritonitis in CAPD patients with two dosage regimens of ofloxacin
5. Peritoneal eosinophilia in CAPD patients, a prospective study
6. Oral treatment of peritonitis complicating continuous ambulatory peritoneal dialysis
7. A prospective randomized trial of oral versus intraperitoneal treatment with cephradine
8. A randomized controlled trial of oral ofloxacin versus intraperitoneal tobramycin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis
9. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis
10. Treatment of CAPD peritonitis with oral ciprofloxacin
11. The importance of intracellular organisms in CAPD